semaglutide chest pain Ozempic (Semaglutide): GLP-1 receptor agonist used for type 2 diabetes. It commonly causes dose-related gastrointestinal side-effects, while important serious warnings include pancreatitis, gallbladder disease, dehydration-related acute kidney injury semaglutide and chest pain Tirzepatide

Very Common Side Effects (Affecting 20% or More) Nausea: 28% of participants Nausea is the most talked-about side effect with GLP-1 class medications, and Retatrutide is no exception

[11] [12] Other key factors include: Dose level : Higher doses (e.g., 12 mg in trial protocols) produced greater weight loss than lower doses, though they were also associated with a higher incidence of gastrointestinal side effects

But as more patients stay on these medications for yearsnot just monthsquestions around GLP1 longterm safety have become essential to address

pain, bloating, flatulence

When to adjust your dose The standard titration assumes a 4-week-per-phase increase

This is one of the most important long-term risks of these medications and is directly addressed by intentional protein timing